complaint·April 5, 2023

Licensing Program Analyst (LPA), Stephanie Torres, conducted an unannounced visit to the facility to start the investigation into the above allegation. The LPA met with Executive Director (ED), Rance Leth, and informed him of the purpose of the visit. A report was received alleging facility staff administered one discontinued medication to Resident One (R1) from February 21, 2023 through March 21, 2023. The LPA conducted staff/resident interviews, reviewed records and took copies of relevant documentation. Medication Aministration Records (MAR) from February and March 2023 were reviewed. The reports revealed the facility did administer to R1, from February 21, 2023 to March 23, 2023, the medication allegedly discontinued. Physican Orders were reviewed and it was found the medication administered to R1 was discontinued on February 21, 2023; however, the document was not signed and dated. Therefore, due to insufficient information, this allegation is deemed UNSUBSTANTIATED at this time. This report was reviewed with Leth and a copy was provided.